Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jul 15;100(2):411–418. doi: 10.1172/JCI119548

Identification of functional endothelial protein C receptor in human plasma.

S Kurosawa 1, D J Stearns-Kurosawa 1, N Hidari 1, C T Esmon 1
PMCID: PMC508205  PMID: 9218519

Abstract

The endothelial cell protein C receptor (EPCR) binds protein C and facilitates activation by the thrombin-thrombomodulin complex. EPCR also binds activated protein C (APC) and inhibits APC anticoagulant activity. In this study, we detected a soluble form of EPCR in normal human plasma. Plasma EPCR appears to be approximately 43, 000 D, and circulates at approximately 100 ng/ml (98.4+/-27.8 ng/ml, n = 22). Plasma EPCR was purified from human citrated plasma using ion exchange, immunoaffinity, and protein C affinity chromatography. Flow cytometry experiments demonstrated that plasma EPCR bound APC with an affinity similar to that previously determined for recombinant soluble EPCR (Kdapp = 30 nM). Furthermore, plasma EPCR inhibited both protein C activation on an endothelial cell line and APC anticoagulant activity in a one-stage Factor Xa clotting assay. The physiological function of plasma EPCR is uncertain, but if the local concentrations are sufficiently high, particularly in disease states, the present data suggest that the soluble plasma EPCR could attenuate the membrane-bound EPCR augmentation of protein C activation and the anticoagulant function of APC.

Full Text

The Full Text of this article is available as a PDF (230.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arend W. P., Malyak M., Smith M. F., Jr, Whisenand T. D., Slack J. L., Sims J. E., Giri J. G., Dower S. K. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. J Immunol. 1994 Nov 15;153(10):4766–4774. [PubMed] [Google Scholar]
  2. Asakura H., Jokaji H., Saito M., Uotani C., Kumabashiri I., Morishita E., Yamazaki M., Matsuda T. Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol. 1991 Dec;38(4):281–287. doi: 10.1002/ajh.2830380406. [DOI] [PubMed] [Google Scholar]
  3. Bock P. E. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl. Biochemistry. 1988 Aug 23;27(17):6633–6639. doi: 10.1021/bi00417a063. [DOI] [PubMed] [Google Scholar]
  4. Bourin M. C., Lindahl U. Glycosaminoglycans and the regulation of blood coagulation. Biochem J. 1993 Jan 15;289(Pt 2):313–330. doi: 10.1042/bj2890313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edgell C. J., McDonald C. C., Graham J. B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734–3737. doi: 10.1073/pnas.80.12.3734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Esmon C. T., Esmon N. L., Harris K. W. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem. 1982 Jul 25;257(14):7944–7947. [PubMed] [Google Scholar]
  7. Esmon C. T., Esmon N. L., Le Bonniec B. F., Johnson A. E. Protein C activation. Methods Enzymol. 1993;222:359–385. doi: 10.1016/0076-6879(93)22024-a. [DOI] [PubMed] [Google Scholar]
  8. Esmon C. T., Owen W. G. Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C. Proc Natl Acad Sci U S A. 1981 Apr;78(4):2249–2252. doi: 10.1073/pnas.78.4.2249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fukudome K., Esmon C. T. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 1994 Oct 21;269(42):26486–26491. [PubMed] [Google Scholar]
  10. Fukudome K., Esmon C. T. Molecular cloning and expression of murine and bovine endothelial cell protein C/activated protein C receptor (EPCR). The structural and functional conservation in human, bovine, and murine EPCR. J Biol Chem. 1995 Mar 10;270(10):5571–5577. doi: 10.1074/jbc.270.10.5571. [DOI] [PubMed] [Google Scholar]
  11. Fukudome K., Kurosawa S., Stearns-Kurosawa D. J., He X., Rezaie A. R., Esmon C. T. The endothelial cell protein C receptor. Cell surface expression and direct ligand binding by the soluble receptor. J Biol Chem. 1996 Jul 19;271(29):17491–17498. doi: 10.1074/jbc.271.29.17491. [DOI] [PubMed] [Google Scholar]
  12. Galvin J. B., Kurosawa S., Moore K., Esmon C. T., Esmon N. L. Reconstitution of rabbit thrombomodulin into phospholipid vesicles. J Biol Chem. 1987 Feb 15;262(5):2199–2205. [PubMed] [Google Scholar]
  13. Gerson W. T., Dickerman J. D., Bovill E. G., Golden E. Severe acquired protein C deficiency in purpura fulminans associated with disseminated intravascular coagulation: treatment with protein C concentrate. Pediatrics. 1993 Feb;91(2):418–422. [PubMed] [Google Scholar]
  14. Hancock W. W., Tsuchida A., Hau H., Thomson N. M., Salem H. H. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant Proc. 1992 Oct;24(5):2302–2303. [PubMed] [Google Scholar]
  15. Heaney M. L., Golde D. W. Soluble cytokine receptors. Blood. 1996 Feb 1;87(3):847–857. [PubMed] [Google Scholar]
  16. Hofsteenge J., Taguchi H., Stone S. R. Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors. Biochem J. 1986 Jul 1;237(1):243–251. doi: 10.1042/bj2370243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Horiuchi S., Koyanagi Y., Zhou Y., Miyamoto H., Tanaka Y., Waki M., Matsumoto A., Yamamoto M., Yamamoto N. Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism. Eur J Immunol. 1994 Aug;24(8):1945–1948. doi: 10.1002/eji.1830240837. [DOI] [PubMed] [Google Scholar]
  18. Ishii H., Majerus P. W. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985 Dec;76(6):2178–2181. doi: 10.1172/JCI112225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Jackman R. W., Beeler D. L., Fritze L., Soff G., Rosenberg R. D. Human thrombomodulin gene is intron depleted: nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci U S A. 1987 Sep;84(18):6425–6429. doi: 10.1073/pnas.84.18.6425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  21. Lu R. L., Esmon N. L., Esmon C. T., Johnson A. E. The active site of the thrombin-thrombomodulin complex. A fluorescence energy transfer measurement of its distance above the membrane surface. J Biol Chem. 1989 Aug 5;264(22):12956–12962. [PubMed] [Google Scholar]
  22. Lust J. A., Donovan K. A., Kline M. P., Greipp P. R., Kyle R. A., Maihle N. J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine. 1992 Mar;4(2):96–100. doi: 10.1016/1043-4666(92)90043-q. [DOI] [PubMed] [Google Scholar]
  23. Mather T., Oganessyan V., Hof P., Huber R., Foundling S., Esmon C., Bode W. The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J. 1996 Dec 16;15(24):6822–6831. [PMC free article] [PubMed] [Google Scholar]
  24. Mathews I. I., Padmanabhan K. P., Tulinksy A., Sadler J. E. Structure of a nonadecapeptide of the fifth EGF domain of thrombomodulin complexed with thrombin. Biochemistry. 1994 Nov 22;33(46):13547–13552. doi: 10.1021/bi00250a006. [DOI] [PubMed] [Google Scholar]
  25. Müllberg J., Oberthür W., Lottspeich F., Mehl E., Dittrich E., Graeve L., Heinrich P. C., Rose-John S. The soluble human IL-6 receptor. Mutational characterization of the proteolytic cleavage site. J Immunol. 1994 May 15;152(10):4958–4968. [PubMed] [Google Scholar]
  26. Ohdama S., Matsubara O., Aoki N. Plasma thrombomodulin in Wegener's granulomatosis as an indicator of vascular injuries. Chest. 1994 Sep;106(3):666–671. doi: 10.1378/chest.106.3.666. [DOI] [PubMed] [Google Scholar]
  27. Owen W. G., Esmon C. T., Jackson C. M. The conversion of prothrombin to thrombin. I. Characterization of the reaction products formed during the activation of bovine prothrombin. J Biol Chem. 1974 Jan 25;249(2):594–605. [PubMed] [Google Scholar]
  28. Parkinson J. F., Grinnell B. W., Moore R. E., Hoskins J., Vlahos C. J., Bang N. U. Stable expression of a secretable deletion mutant of recombinant human thrombomodulin in mammalian cells. J Biol Chem. 1990 Jul 25;265(21):12602–12610. [PubMed] [Google Scholar]
  29. Quehenberger P., Loner U., Kapiotis S., Handler S., Schneider B., Huber J., Speiser W. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives. Thromb Haemost. 1996 Nov;76(5):729–734. [PubMed] [Google Scholar]
  30. Regan L. M., Stearns-Kurosawa D. J., Kurosawa S., Mollica J., Fukudome K., Esmon C. T. The endothelial cell protein C receptor. Inhibition of activated protein C anticoagulant function without modulation of reaction with proteinase inhibitors. J Biol Chem. 1996 Jul 19;271(29):17499–17503. doi: 10.1074/jbc.271.29.17499. [DOI] [PubMed] [Google Scholar]
  31. Reitsma P. H., Bernardi F., Doig R. G., Gandrille S., Greengard J. S., Ireland H., Krawczak M., Lind B., Long G. L., Poort S. R. Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommittee on Plasma Coagulation Inhibitors of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995 May;73(5):876–889. [PubMed] [Google Scholar]
  32. Rezaie A. R., Cooper S. T., Church F. C., Esmon C. T. Protein C inhibitor is a potent inhibitor of the thrombin-thrombomodulin complex. J Biol Chem. 1995 Oct 27;270(43):25336–25339. doi: 10.1074/jbc.270.43.25336. [DOI] [PubMed] [Google Scholar]
  33. Rivard G. E., David M., Farrell C., Schwarz H. P. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr. 1995 Apr;126(4):646–652. doi: 10.1016/s0022-3476(95)70369-1. [DOI] [PubMed] [Google Scholar]
  34. Sadler J. E., Lentz S. R., Sheehan J. P., Tsiang M., Wu Q. Structure-function relationships of the thrombin-thrombomodulin interaction. Haemostasis. 1993 Mar;23 (Suppl 1):183–193. doi: 10.1159/000216927. [DOI] [PubMed] [Google Scholar]
  35. Stearns-Kurosawa D. J., Kurosawa S., Mollica J. S., Ferrell G. L., Esmon C. T. The endothelial cell protein C receptor augments protein C activation by the thrombin-thrombomodulin complex. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10212–10216. doi: 10.1073/pnas.93.19.10212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Stearns D. J., Kurosawa S., Sims P. J., Esmon N. L., Esmon C. T. The interaction of a Ca2+-dependent monoclonal antibody with the protein C activation peptide region. Evidence for obligatory Ca2+ binding to both antigen and antibody. J Biol Chem. 1988 Jan 15;263(2):826–832. [PubMed] [Google Scholar]
  37. Suzuki K., Kusumoto H., Deyashiki Y., Nishioka J., Maruyama I., Zushi M., Kawahara S., Honda G., Yamamoto S., Horiguchi S. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J. 1987 Jul;6(7):1891–1897. doi: 10.1002/j.1460-2075.1987.tb02448.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Takahashi H., Hanano M., Wada K., Tatewaki W., Niwano H., Tsubouchi J., Nakano M., Nakamura T., Shibata A. Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol. 1991 Nov;38(3):174–177. doi: 10.1002/ajh.2830380304. [DOI] [PubMed] [Google Scholar]
  39. Takahashi H., Ito S., Hanano M., Wada K., Niwano H., Seki Y., Shibata A. Circulating thrombomodulin as a novel endothelial cell marker: comparison of its behavior with von Willebrand factor and tissue-type plasminogen activator. Am J Hematol. 1992 Sep;41(1):32–39. doi: 10.1002/ajh.2830410107. [DOI] [PubMed] [Google Scholar]
  40. Takano S., Kimura S., Ohdama S., Aoki N. Plasma thrombomodulin in health and diseases. Blood. 1990 Nov 15;76(10):2024–2029. [PubMed] [Google Scholar]
  41. Tanaka A., Ishii H., Hiraishi S., Kazama M., Maezawa H. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem. 1991 Feb;37(2):269–272. [PubMed] [Google Scholar]
  42. Taylor F. B., Jr, Chang A., Esmon C. T., D'Angelo A., Vigano-D'Angelo S., Blick K. E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987 Mar;79(3):918–925. doi: 10.1172/JCI112902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Wada H., Ohiwa M., Kaneko T., Tamaki S., Tanigawa M., Shirakawa S., Koyama M., Hayashi T., Suzuki K. Plasma thrombomodulin as a marker of vascular disorders in thrombotic thrombocytopenic purpura and disseminated intravascular coagulation. Am J Hematol. 1992 Jan;39(1):20–24. doi: 10.1002/ajh.2830390106. [DOI] [PubMed] [Google Scholar]
  44. Wen D. Z., Dittman W. A., Ye R. D., Deaven L. L., Majerus P. W., Sadler J. E. Human thrombomodulin: complete cDNA sequence and chromosome localization of the gene. Biochemistry. 1987 Jul 14;26(14):4350–4357. doi: 10.1021/bi00388a025. [DOI] [PubMed] [Google Scholar]
  45. Ye J., Esmon N. L., Esmon C. T., Johnson A. E. The active site of thrombin is altered upon binding to thrombomodulin. Two distinct structural changes are detected by fluorescence, but only one correlates with protein C activation. J Biol Chem. 1991 Dec 5;266(34):23016–23021. [PubMed] [Google Scholar]
  46. Ye J., Liu L. W., Esmon C. T., Johnson A. E. The fifth and sixth growth factor-like domains of thrombomodulin bind to the anion-binding exosite of thrombin and alter its specificity. J Biol Chem. 1992 Jun 5;267(16):11023–11028. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES